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Host species adaptation of TLR5 
signalling and flagellin recognition
Amin Tahoun1,4, Kirsty Jensen1, Yolanda Corripio-Miyar  1,5, Sean McAteer1, David G. E. 
Smith2,3,6, Tom N. McNeilly  5, David L. Gally1 & Elizabeth J. Glass  1
Toll-like receptor 5 (TLR5) recognition of flagellin instigates inflammatory signalling. Significant 
sequence variation in TLR5 exists between animal species but its impact on activity is less well 
understood. Building on our previous research that bovine TLR5 (bTLR5) is functional, we compared 
human and bovine TLR5 activity and signalling in cognate cell lines. bTLR5 induced higher levels of 
CXCL8 when expressed in bovine cells and reciprocal results were found for human TLR5 (hTLR5) in 
human cells, indicative of host cell specificity in this response. Analysis of Toll/interleukin-1 receptor 
(TIR) sequences indicated that these differential responses involve cognate MyD88 recognition. siRNA 
knockdowns and inhibitor experiments demonstrated that there are some host differences in signalling. 
Although, PI3K activation is required for bTLR5 signalling, mutating bTLR5 F798 to hTLR5 Y798 within 
a putative PI3K motif resulted in a significantly reduced response. All ruminants have F798 in contrast to 
most other species, suggesting that TLR5 signalling has evolved differently in ruminants. Evolutionary 
divergence between bovine and human TLR5 was also apparent in relation to responses measured to 
diverse bacterial flagellins. Our results underscore the importance of species specific studies and how 
differences may alter efficacy of TLR-based vaccine adjuvants.
Toll-like receptors (TLRs) are the most studied of the key pattern recognition receptors (PRRs) in multicellular 
eukaryotic hosts that function to recognise pathogen invasion and signal danger, leading to cascades of defensive 
responses (reviewed by 1). Mammals have between 1 and 13 distinct TLRs which are specific for various mole-
cules expressed by pathogens1. TLRs are membrane-bound proteins mainly expressed in compartments that are 
entryways for invading pathogens such as the cell surface or endosome of innate immune cells and epithelial cells. 
Each TLR contains a ligand binding ecto-domain as well as an intracellular Toll-Interleukin receptor domain 
(TIR). Ligand binding results in conformational changes in the TLR and triggers signalling cascades involving 
interactions between the TIR domain and various adapters, for example MyD88, which can also possess a TIR 
domain1.
Although TLRs are relatively well conserved between species, in recent years it has become evident that there 
are potentially functionally important species differences in TLRs in both the ligand binding and TIR domains2. 
Non-synonymous amino acid substitutions and polymorphisms potentially reflect adaptations as a result of expo-
sure to distinct pathogens during the life history of particular hosts3,4. These differences may underlie the varying 
way in which different host species respond to pathogens and have significant consequences for predicting the 
outcomes of infection and vaccination5. Thus the use of TLR ligands as potent adjuvants in vaccines may require 
modification according to species-specific sequence differences in key residues in TLR molecules.
TLR5 is the only TLR that recognises a protein ligand, flagellin which forms the core of the main motility 
organelle of flagellated bacteria and consequently flagellin constructs have been explored as potential vaccine 
components in various host species including humans6 and cattle7. Our earlier studies had indicated that bovine 
TLR5 contains a number of positively selected sites in the extracellular and intracellular domains2,7. We also 
have also recently shown that contrary to some reports8,9, bovine TLR5 (bTLR5) is functional in both human 
(HEK293) and bovine epithelial cell lines (EBL), as well as in bovine macrophages. Signalling through bTLR5 
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with H7 flagellin ligand derived from E. coli O157 resulted in NFκB reporter activation and up-regulation of 
CXCL8 mRNA in these cells as well as secretion of the chemokine7. In addition, TLR5-specific knock-down 
using siRNA significantly reduced the response to flagellin in bovine macrophages7. However, it was noted that 
in a human cell line (HEK cells), at low concentrations of flagellin, human TLR5 (hTLR5) was somewhat more 
responsive than bTLR5, indicating that amino acid differences between bovine and human TLR5 may result in 
differences in flagellin binding and/or signalling7.
The major binding interaction between TLR5 and flagellin was identified as TLR5 leucine rich repeat (LRR)9 
with the flagellin D1 domain, especially the highly conserved R90 residue10. Mutation of R90 to other residues 
abrogates activation of both human TLR511 as well as bovine TLR57, confirming the importance of the LRR9 
region across a wide range of species. Furthermore cattle immunised with E. coli O157 H7 flagellin consistently 
had lower humoral responses with R90 mutated to T90 compared to the wild-type flagellin7.
In the current study, we sub-cloned the TLR5 of both species into a modified ptGFP1 vector12 and transfected 
these constructs into both HEK293T (human) and EBL (bovine) cell lines. This ensured that a high percentage 
of cells (90–95%) expressed the constructs to enable valid comparisons in responses induced by the TLRs and in 
different host cell backgrounds. We then explored the signalling pathways utilised by the TLR5 variants in both 
their cognate and distinct host backgrounds as well as their relative responsiveness to flagellins purified from 
different bacterial genera.
Results
Comparison of human and human TLR5 signalling in cells lines from the two different 
hosts. From previous published research, it was evident that when using lower levels of H7 flagellin, HEK cells 
transfected with bovine TLR5 were less responsive when transfected with human TLR57. While this may be due 
to functional differences in TLR5 activity, at the time we could not rule out that it may be due to lower expression 
levels of bovine TLR5. To our knowledge, there is no commercial anti-human TLR5 monoclonal or polyclonal 
antibody that also detects bovine TLR5. As an alternative, the required TLR was expressed in tandem with GFP 
using a modified ptGFP vector (Materials and Methods)7. GFP positive transfected cells were sorted to high GFP 
positivity. These cells also had similar mean fluorescent intensities (MFI) (Supplementary Fig. S1). Using this 
approach, HEK-293T or EBL were transfected with either the human or the bovine TLR5 clone, which enabled us 
to directly compare their responses to H7 flagella (Fig. 1a–d). In the human HEK background the bovine TLR5 
had a significantly reduced response (p < 0.001) to H7 flagellin and post-hoc analysis indicated that this was at 
every dose (0.5 ng/ml to 50,000 ng/ml) of H7 compared to the human TLR5 (p < 0.05 for each dose) (Fig. 1(a)). 
By contrast, the complete reversal of this occurred when the same human and bovine TLR5 GFP clones were 
transfected into a bovine lung epithelial cell line (EBL) (Fig. 1(b)). In this case, the bTLR5 was significantly more 
responsive to H7 (p < 0.001) and across a range of H7 concentrations, from 50 ng/ml to 50,000 ng/ml, compared 
to hTLR5 (p < 0.05 for each dose) (Fig. 1B). (In Supplementary Fig. S2 the levels of CXCL8 in pg/ml are shown for 
each condition, along with the background levels for the non-transfected cells).
Site specific mutation of bovine TLR5. Since we had, as far as possible, controlled for expression levels 
of each TLR5 in the two transfected cell lines, we interpret the data to show that there is a host species incompat-
ibility in the interaction of TLR5 and its intracellular partners, leading to differences in signalling. To examine 
this, we compared the amino acid sequence of the intracellular signalling TIR domain of human and bovine TLR5 
(Fig. 2). As there are now additional artiodactyla and ruminant TLR5 sequences available, compared to the anal-
ysis in our earlier paper2 we re-analysed this new data-set (Supplementary Table S1) focusing on a comparison 
Figure 1. The activity of bovine and human TLR5 differs with cell background. CXCL8 protein release from  
(a) HEK293T cells and (b) EBL cells stably transfected with human TLR5 (♦) or bovine TLR5 (■), activated 
with E. coli H7 flagellin at various concentrations. The Figures show the average CXCL8 protein response for 
each H7 concentration as a percentage of the background response in non-transfected cells. The error bars 
illustrate the standard error of the mean for three experiments, each with three technical replicates. The average 
CXCL8 protein release in response to flagellin was significantly different in cells expressing bovine or human 
forms of TLR5 by ANOVA (P < 0.001) and * denotes which doses were significant by subsequent Tukey’s test 
(P < 0.05).
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with human and other vertebrate species (Supplementary Fig. S3). The TIR region of TLR5 is extremely highly 
conserved across species compared to the extracellular domain. Across TIR domain proteins, a set of motifs 
and conserved residues have been identified although their functional significance remains unclear13–15 with the 
majority not having been formally tested for TLR5. In general, the various motifs and potential intra-domain and 
inter-domain interaction motifs are conserved across the TLR5 sequences with very few changes in the putative 
functional sites (Fig. 2; Supplementary Fig. S3).
However, there are three exceptions that may underlie functional differences in signalling between cattle 
and human TLR5 molecules (Fig. 2; Supplementary Fig. S3). First, the additional ruminant and cetartiodactyla 
sequences now available indicate that of two amino acids previously identified as positively selected2,16, H720 
is a Bos-specific change and S721 is a Ruminantia-specific change. Second, a motif within the BB loop, RDXXP 
which likely interacts with MyD8815, has a Ruminantia-specific change to RDFMP which is distinct from all 
other species where the motif is RDFI/V/LP (Supplementary Fig. S3). Third, two contiguous amino acids that are 
contained in a putative PI3K motif17 within the DD loop are clearly distinct in ruminants being “FH” whereas in 
almost all other species, including human, the motif is “YQ” (Supplementary Fig. S3). Osvaldova and colleagues9 
suggested that this difference resulted in an inability of bTLR5 to signal, and replaced FH for YQ in bTLR5 with 
partial restoration of its activity in HEK cells. However, our data above demonstrates that wild-type bTLR5 is able 
to signal in both a human and bovine cell background, despite the lack of this putative PI3K motif.
Given the conflicting data between our study and that of Osvaldova et al.9, we initially exchanged the bTLR5 
amino acid F at position 798 with Y as present in the hTLR5. We investigated the response of the mutated bTLR5 
(bTLR5F798Y) and compared its activity with the wild-type bTLR5 in both human HEK and bovine EBL cells 
(Fig. 3(a) and (b)). The same GFP-containing vector background and cell sorting were used to achieve high 
expression levels of the bTLR5F798Y variant (Supplementary Fig. S1). There was a significantly lower response 
to flagellin for the bovine mutant bTLR5F798Y compared to bovine wild-type TLR5 H7 (p < 0.001) in HEK cells 
Figure 2. Comparison of human and bovine sequence alignment of the TIR domain of TLR5. Potentially 
functionally relevant positions are shown (using clustal omega and displayed using Jalview). The position of 
Boxes 1–342, RDXXP motif15 and putative PI3 kinase motif2 are shown as black outlines; red vertical arrow 
indicates the partially conserved S805 that may be phosphorylated by PKD and required for signalling43; BB 
loop and DD loop42 are indicated by the horizontal blue arrows; red stars indicate similar or conserved amino 
acids across TIR domains of animals, plants and bacteria14; brown stars are totally conserved and blue stars are 
semi-conserved residues across TLR TIR domains13 and H1–4 indicate positions that have been identified as 
conserved hubs of communication between ectodomain and TIR domain following ligand binding13; the double 
green vertical arrows indicate: H720 and S721 identified as positively selected2,16, respectively.
Figure 3. The effect of a mutation in the cytosolic region of bovine TLR5 differs with cell background. CXCL8 
protein release was measured in (a) HEK293T cells or (b) EBL cells stably transfected with wild-type bovine 
TLR5 (■) or F798Y mutant (▲) after stimulation with 0.5–50,000 ng/ml E. coli H7 flagellin. The graph shows 
the average protein response as a percentage of the background response in non-transfected cells. The error bars 
illustrate the standard error of the mean of three experiments, each with three technical replicates. The average 
CXCL8 protein release in response to flagellin was significantly different in cells expressing bovine wild-type 
or mutant bTLR5F798Y forms of TLR5 by ANOVA (P < 0.001) and * denotes which doses were significant by 
subsequent Tukey’s test (P < 0.05).
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(Fig. 3(a); Supplementary Fig. S4(a)). Significantly and in contrast to the result in the HEK cells, bTLR5F798Y 
expression in EBLs resulted in substantially ablated responses to H7 compared to the wild type molecule and 
was indistinguishable from the response by untransfected cells (P < 0.001) (Fig. 3(b); Supplementary Fig. S4(b)).
The role of PI3K signalling in host specific TLR5 signalling. We then investigated the role of PIK3RI 
regulatory subunit of PI3K in TLR5 signalling using both siRNA and a PI3K inhibitor comparing hTLR5 responses 
in HEK cells with bTLR5 responses in EBL. The CXCL8 response induced by interaction of hTLR5 with H7 flagel-
lin was reduced but not significantly by siRNA for PIK3R1, which knocks down expression of all three regulatory 
subunits of class IA PI3K encoded by the human PIK3R1 gene: p85A, p55A and p50A (Fig. 4(a)). Furthermore, no 
inhibition was observed when the PI3K inhibitor LY294002 was added to the interaction (Fig. 4(b)). In contrast, 
siRNAs designed to different regions of the bovine PIK3R1 gene had different effects on the CXCL8 response driven 
by flagellin activation of bTLR5 expressed in EBL cells (Fig. 4(c)). PIK3R1#b3 resulted in significant inhibition of 
the response, whereas PIK3R1#b2 resulted in enhancement of the CXCL8 response. PIK3R1#b3 is predicted to 
recognize all splice variants, thereby reducing levels of all three regulatory subunits encoded by PIK3R1, and is 
therefore comparable to the siRNA against human PIK3R1. In contrast, PIK3R1#b2 is predicted to only recognize 
the splice variant encoding the p85A regulatory subunit. The inhibitor, LY294002 in contrast to the effects on hTLR5 
activation, significantly ablated the response of bTLR5 to H7 flagellin (Fig. 4(d)), in agreement with the result for 
Figure 4. Blocking TLR signalling with down-stream inhibitors and targeted siRNA reveals similarities and 
differences between human and bovine signalling pathways. HEK293T cells stably transfected with human 
TLR5 (a) and EBL cells stably transfected with bovine TLR5 (c) were transiently transfected with siRNA for 
p38, RELA, TRAF6 and PIK3R1. PIK3R1 (human) and PIK3R1#b3 (bovine) are predicted to recognize all 
splice variants, thereby reducing levels of all three regulatory subunits of class IA PI3K encoded by human or 
bovine PIK3R1 respectively; PIK3R1#b2 (bovine) is predicted to only recognize the splice variant encoding 
the p85A regulatory subunit. In addition, cells were treated with transfection reagent only (TC) or transfected 
with non-target control siRNA (NTC). After 24hr cells were activated with 100 ng/ml E. coli H7 flagellin. The 
graphs illustrates the average release of CXCL8 protein relative to that released by NTC samples. The error bars 
illustrate the standard error of the mean of three experiments, each with three technical replicates. HEK293T 
cells stably transfected with human TLR5 (b) and EBL cells stably transfected with bovine TLR5 (d) were 
treated with inhibitors of p38 (5 μM SB203580), NF-κB (100 μM PDTC) and PI3K (50 μM LY294002) or DMSO 
before stimulation with ng/ml E. coli H7 flagellin. The graphs illustrates the average release of CXCL8 protein 
relative to that released by DMSO treated samples. The error bars illustrate the standard error of the mean of 
three experiments, each with three technical replicates. *Denotes that the average CXCL8 level was statistically 
significantly different from (a and c) NTC or (b and d) DMSO and H7 treated samples by ANOVA and 
subsequent Tukey’s test (P < 0.05).
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PIK3R1#b3. This data demonstrates that TLR5 activation by bTLR5 in a cognate bovine cell line requires PIK3, 
whereas there was no evidence for this in the parallel human system.
Comparative analysis of TRAF6, RELA and p38 in host specific TLR5 signalling. We also inves-
tigated the role of TRAF6, RELA subunit of NFκB and p38 using siRNA knock-down and specific inhibitors. As 
expected, RELA knock-down and the presence of PDTC, an inhibitor of NFκB, resulted in substantial reduction 
of CXCL8 production in response to H7 flagellin by hTLR5 in the HEK background (p < 0.05) (Fig. 4(a) and 
(b) respectively). Similar findings were obtained for bTLR5 in EBL with RELA siRNA leading to ablation of the 
CXCL8 response (p < 0.05) (Fig. 4(c)). However, in contrast, the inhibitor PDTC resulted in enhanced release of 
CXCL8 in the bovine combination (Fig. 4(d)). Knock-down of TRAF6 resulted in similar reduction in CXCL8 
production in response to hTLR5 in HEK or bTLR5 in EBL (Fig. 4(a) and (c) respectively). For the p38 pathway 
we observed further discrepancies between the siRNA knock-down and inhibitors. p38 siRNA had no effect on 
the CXCL8 response of hTLR5 in HEK (Fig. 4(a)) whereas the presence of the p38 inhibitor, SB203580, led to a 
significant reduction in activity (Fig. 4(b)). However, both siRNA for p38 and its inhibitor reduced the response 
of bTLR5 to H7 flagellin in EBL (Fig. 4(c) and (d)). These results indicate that hTLR5 and bTLR5 both signal 
through TRAF6 to the NFκB and p38 dependent pathways, albeit with some potential differences.
Differential activation of host-specific TLRs by flagellin preparations from different bacterial 
genera. Our earlier studies2,7 had also indicated that bovine TLR5 contains a number of positively selected 
sites in the extracellular domain which might also account for functional differences between bTLR5 and 
hTLR5. Table 1 compares the key regions in the ectodomain of human, bovine and zebrafish TLR5. These are 
the main flagellin binding regions: LRRNT-LRR6 (interface A) which bind to the C-terminal half of flagellin D1 
domain and LRR7-LRR10 (interface B) which bind to the N-terminal half of the flagellin D1 domain. A total of 
thirty-three amino acids within both interfaces of zebrafish TLR5 were identified as interacting with flagellin. Of 
the five amino acids that are conserved across all three species (S6, G266, F269, N273 and K275 (numbered as 
for bovine TLR5)), four are within the major binding region, LRR910, highlighting the major importance of this 
LRR. We re-analysed our artiodactyla-focused data-set of TLR5 sequences (Supplementary Table S1) comparing 
these to human and other vertebrate species (Supplementary Fig. S5). Six of the thirty-three TLR5 binding res-
idues were previously identified as under positive selection2,16 (Table 1). The new data reveals that five of these 
are restricted to Ruminantia (L34, G104, G239, S268 and S272), with the latter two residues also within LRR9 
(Table 1; Supplementary Fig. S5). Q207 is restricted to Bos species, and all other ruminants have Histidine at this 
position whereas most other species express different residues. In addition, a further four TLR5 binding amino 
acids are clearly associated with Bos and Bison species (S128, F179, K181 and R261) or with the Ruminantia clade 
(Y297). Taken together, these host specific differences between human and bovine TLR5 could result in differing 
interactions with flagellins that vary in their TLR5 interacting primary sequences within the D1 domain of the 
flagellin subunit.
In order to explore this further, we compared the sequence of the two TLR5 binding domains (Nt D1 and Ct 
D1) of E. coli H7 flagellin with the equivalent sequences of specific flagellins that encompass variations in their 
TLR5 binding domains (Fig. 5(a)). These included S. Dublin, S. Typhimurium, L. ivanovii and B. thailandensis 
flagellins. The flagellins from L. ivanovii and B. thailandensis are quite distinct from each other and from those 
expressed by both Salmonella and E. coli which are closely related irrespective of the serogroup selected (Table 1 
and Fig. 5(a)). Eleven of the 31 amino acids identified by Yoon et al.10 as important for S. Dublin flagellin recog-
nition, are conserved between all five flagellins including R90, E114 and Q97 (Fig. 5(a)) These three amino acids 
make 9 interactions with the major LRR9 TLR5 binding site, the majority of which are to highly conserved TLR5 
amino acids (Table 1). Indeed, in total, the conserved amino acids in flagellins mainly interact with conserved 
TLR5 amino acids (Table 1 and Fig. 5(a)).
However, there are a few differences between these flagellins in their binding amino acids that coincide with 
differences between human and bovine binding amino acids. For example R118 in E. coli and Salmonella is 
exchanged with Q118 and L118 in B. thailandensis and L. ivanovii Nt D1 flagellin domain, and is reflected in 
ruminant specific substitutions in bTLR5: S268 and Y297 in LRR9 and LRR10, compared to hTLR5: G268 and 
F297 (Fig. 5(a), Table 1, Supplementary Fig. S5).
In order to test whether any of the differences in the human and bovine TLR5 ectodomains resulted in dif-
ferences in the way they interacted with these flagellins, we compared the relative CXCL8 responses of hTLR5 
in HEK cells with bTLR5 in EBL cells to flagellin preparations from these different bacterial species. The relative 
responses of hTLR5 and bTLR5 to three of these flagellin preparations were then compared directly to their E. 
coli (H7) responses (Fig. 5(b)). There was no significant difference in their relative responses to S. Typhimurium 
flagellins. In contrast, there was a significant reversal in the relative responses of hTLR5 and bTLR5 to the more 
diverse flagellins isolated from L. ivanovii and B. thailandensis (p < 0.001).
Discussion
TLRs are fundamental components of the innate response and understanding variation in pattern recognition 
and signalling by related TLRs in different host species provides insights into differences in infection pressure 
that drive their evolution. This study has analysed the functional differences between human and bovine TLR5 
homologues and reaches two significant conclusions1: that these TLR5s do not use identical signalling pathways 
in their respective hosts to induce inflammation and2 that the two TLR5s differ in their interactions with flagellin. 
Taken together our data suggest that effective TLR5 signalling in each species reflects co-evolution of the TLR5 
molecules with the repertoire of flagellated bacterial pathogens that have affected their hosts, as well as with 
the TLR5-adaptor proteins and signalling components. These observations have important implications for the 
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application of immune-modulators, signalling inhibitors and PAMP-based adjuvants for use in animals especially 
in terms of interpretation of data from experimental studies in mice and humans.
There have been several reports of species specific differences in TLR5 which result in functional 
changes2,7–9,18–20; most of these papers have used human cell lines to investigate host species specificity. We have 
shown that bovine TLR5, in contrast to some earlier reports8,9, is fully functional in both a bovine and human 
cell line background, as well as in bovine macrophages and, importantly, is active in vivo7. However, we could 
not rule out the possibility that some of the down-stream differences between hTLR5 and bTLR5 were a result of 
differences in expression in the cell lines. As a suitable anti-bTLR5 antibody was not available, we used a modi-
fied ptGFP1 vector12 which enabled us to flow sort transfected cell lines to high purity, with the majority of cells 
expressing hTLR5 or bTLR5 at similar fluorescence levels. Although we cannot categorically rule out that this 
approach may have not resulted in equivalent numbers of molecules of hTLR5 and bTLR5 at the cell surface, the 
proportion of transfected cells expressing each TLR5 was generally greater than 90% GFP positive with similar 
MFI levels. Furthermore, the clear differences in the dose response curves for each species’ TLR5 between the 
human and bovine cell lines strongly suggest that the differences described in this paper reflect differences in 
TLR5 biology between hTLR5 and bTLR5, rather than differences in levels of cell surface TLR5. Additionally, by 
transfecting each TLR5 into both cell lines with different host backgrounds, it was possible to explore the effect of 
host species differences in the extracellular domains separately from differences in the TIR region.
TLR5 Primary binding interface-A/flagellin D1-Ct TLR5 Primary binding interface-B/flagellin D1-Nt
LRR
TLR5 Flagellins
LRR
TLR5 Flagellins
Bov Hum Zb S.D. FliC
S.T 
FliC
E.c 
H7
L.i 
FlaA
B.t 
FlaA Bov Hum Zb S.D FliC
S.T 
FliC
E.c 
H7
L.i 
FlaA
B.t 
FlaA
LRRNT I32 F32 I33 N438 N N N T LRR7 Q207* S207 T208 Q89 Q Q Q Q
LRRNT L341 R34 I35 S434, T437, N438 S,T, N
S, T 
N
Y, S 
N
A, 
T T LRR7 Y209 Y209 Q210* D412
4, R92* D, R D, R D, R D, R
LRRNT S35 F35 N36 E1532, A435 E, A E, A D, N Q, I LRR7 — — N213 E93 E E Q Q
LRRNT C36 C36 R37* N438* N N N T LRR7 V212 V212 Y215 V96, Q97, N100, G1016
V, Q, 
N, S
V, 
Q,T, 
G
V, Q, 
N, G
V, Q, 
N, G
LRR1 L52 L52 D53 T437 T T S T LRR8 G239 T239 K242* E93, Q97* E, Q E, Q Q, Q Q, Q
LRR1 S54 S54 S55 S434 S S Y A LRR9 R261 H261 N265 N82, N86 N, N S, N S, S T, N
LRR1 F55 F55 L56 R431, S434 R, S R, S R, Y R, A LRR9 H263 H263 Y267† N86, Q89, R90*
N, Q, 
R
N, Q, 
R
S, Q, 
R
N, Q, 
R
LRR2 E76 E76 K77 T437 T T S T LRR9 I264 I264 N268 R90, E93 R, E R, E R, Q R, Q
LRR2 G78 G78 E79* N430* N N S N LRR9 G266 G266 G270†† R90** R R R R
LRR2 T79 S79 Q80** A427, N430*, R431* A, N, R
A, N, 
R
A, S, 
R
A, N, 
R LRR9 S267
5 A267 S271† R90* R R R R
LRR3 G104 S104 Y105 G426, A427, N430
G, A, 
N
G, A, 
N
G, 
A, S
G, A, 
N LRR9 S268 G268 S272* R118* R R L Q
LRR4 S128 F128 Q129* S423†, A427 S, A S, A A, A A, A LRR9 F269 F269 F273 Q117 Q S S Q
LRR5 K154 K154 D155** R422**, S423 R, S R, S R, A Q, A LRR9 F271 F271 H275* D113, E114, Q117*
A, E, 
Q
D, 
E, S
A, 
E, S
Q, E, 
Q
LRR6 F179 S179 F180 E783, R422 E, R E, R D, R S, Q LRR9 S2727 H272 T276 S110 S S Q A
LRR6 K181 Q181 K182* D419* D D S N LRR9 N273 N273 N277†***
L94, Q97*, 
S110†, I111†, 
E114*
L, 
Q, S, 
I, E
L, 
Q, S, 
I, E
L, Q, 
Q, 
Y, E
L, Q, 
A, 
L, E
LRR9 L274 I274 F278 R90, E93, L94, Q97
R, E, 
L, Q
R, E, 
L, Q
R, Q, 
L, Q
R, Q, 
L, Q
LRR9 K275 K275 K279 Q97 Q Q Q Q
LRR10 Y297 F297 K303 N87, R90, R118
N, 
R, R
N, 
R, R
I, 
R, L
S, R, 
Q
Table 1. Comparison of amino acids involved in binding between human, bovine & zebrafish TLR5 & flagellins. 
Bov = bovine; Hum = human; Zb = zebrafish; S.D. = Salmonella enterica serovar Dublin; S.T. = Salmonella 
enterica serovar Typhimurium; E.c. = E. coli; L.i. = Listeria ivanovii; B.t. = Burkholderia thailandensis. Flagellin 
amino acid numbering according to Smith et al. (2003)11; TLR5 amino acid numbering: for Zb, according to 
Yoon et al. (2012)10; for Bov & Hum, according to Smith et al. (2012)2. 1Positive selection detected in Bos or 
Ruminantia clades1,2, or associated with these species (this paper) is shown in bold; Conserved TLR5 amino 
acids across host species shown in italic; R90 is completely conserved across all five flagellins and is shown in 
bold-underline; 2Not shown in Fig. 5 as is located in the non D1 domains of flagellins; 3interface-A/Flagellin 
D1-Nt interaction; 4interface-B/Flagellin D1-Ct interaction; 5P in mice is sufficient to account for species 
specific binding33 (≡P268 in their paper) & alters LRR9 loop structure compared to human25; 6Flagellin amino 
acids shown in bold are not conserved between Salmonella Dublin and S. Typhimurium; 7Q in mice is sufficient 
to alter the shape of the LRR9 loop compared to human LRR9 loop19. *H-bond or † salt bridge interactions 
that involve a side chain (multiple * or † reflect the number of H-bonds/salt bridges) according to Yoon et al. 
(2012)10.
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Stronger responses to flagellin were observed with hTLR5 than bTLR5 in cells with a human background 
whereas in contrast, the identical bTLR5 construct was activated to a significantly higher level in EBLs than was 
hTLR5. This suggested that the optimum interaction between TLR5 and its adapters and down-stream signalling 
molecules may be species dependent. Until now, this has not been considered, partly because there is higher con-
servation between the transmembrane and TIR region sequences and also different species’ TLR5 constructs have 
shown functional activity in human cell lines, even those that are quite evolutionarily distinct from mammals 
such as chicken and reptile TLR518,20. Our data would suggest that this approach may mask important differences 
in signalling as well as flagellin binding. Thus studies that compare TLR activity and specificity between species 
may require cells of the appropriate species, as otherwise erroneous conclusions may be drawn.
In general, the TIR domain of proteins contains highly conserved loops and motifs (boxes) believed to play a 
role in recruiting adapters and in dimerisation of TLR monomers following ligand binding21. Several TIR domain 
structures have been described and some have been crystallised (summarised by Ve and colleagues14). The loops 
are very close to regions that are highly conserved among all TLRs and between species and may act as part of 
an evolutionarily conserved interaction network between different TIR containing proteins13. However, confor-
mational differences between different TIR domain containing proteins exist, and two of the so-called conserved 
motifs (boxes 2 and 3) are in fact not that well conserved, with evidence that other regions may also play func-
tionally important roles14.
As with most other TLRs, TLR5 first interacts with the IL-1R/TIR containing adapter MyD8821 which cou-
ples the cell surface TLR5 to down-stream intracellular signalling pathways through TRAF622. This results in 
the activation of transcription factors such as NFκB and the MAPK pathways including p38 which leads to the 
production of pro-inflammatory cytokines, such as CXCL823. However, there have been relatively few papers 
that detail the structure-function relationships between the TIR domain of TLR5 and its downstream partners, 
and even fewer that have investigated these interactions in species other than man and mouse. By analogy with 
other better studied TLRs, it is likely that TLR5-MyD88 interaction occurs at least in part through the BB and DD 
Figure 5. Diverse flagellin alignments of Nt and Ct D1 domains, indicating identified TLR5 binding amino 
acids and relative responses to these by bovine and human TLR5. (a) 1Numbering according to Smith et al.  
(2003)11. 2Blue amino acids bind to TLR5 binding interface-B; green amino-acids bind to TLR5 binding 
interface-A, according to Yoon et al. (2012)10; Black amino acids bind to TLR5 according to Smith et al. (2003)11. 
aas: amino acids. (b) The relative CXCL8 protein release from HEK293T cells stably transfected with human 
TLR5 and EBL cells stably transfected with bovine TLR5 after stimulation with 50ng/ml S. Typhimurium P1  
(St P1), Listeria ivanovii FlaA (Li FlaA) and Burkholderia thailandensis FliC (Bt FliC) compared to the response 
to E. coli H7 (Ec H7). Error bars illustrate the standard errors of the mean for three experiments, each with three 
technical replicates. *Denotes that the average CXCL8 protein release in response to the different flagellin was 
significantly different by ANOVA and subsequent Tukey’s test (P < 0.05).
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loops within the TIR domains of TLR5 and MyD88. However, TIR domain loops are divergent among different 
TLRs and these differences play a role in the specific outcomes of TLR engagement with ligands. The BB loop in 
TLR5 contains a highly conserved motif RDxφ1φ2G with a conserved Pro at φ2 which occupies the tip of the loop 
and is essential for TLR5 activity24. However the TLR5 BB loop motif has one amino acid change between cow 
and human (RDFMP and RDFVP respectively) which has been conserved across Ruminantia species and may 
therefore be functionally relevant. Evidence has indicated that the BB motif in other TLRs interacts with a bind-
ing site (BS III) in MyD88 near the N-terminus15. The core residues in MyD88 BS III, W284, R288 and K291, are 
conserved between bovine MyD88 and human MyD88 (data not shown). However bMyD88 differs by two amino 
acids at the start of this site from the human form of MyD88, being Q-N rather than K283-S284. These changes 
are again Ruminantia-specific, suggesting that they may have a functional consequence. Further work is needed 
to confirm whether or not these changes are at least in part responsible for the differences observed in activation 
associated with distinct cell backgrounds.
Similar to the BB loop, the DD loop in TLR5 likely extends beyond the TIR domain. For other TLRs, this 
loop has been shown to play a role in both homo- and hetero-dimerisation of TLRs and also between TLRs and 
adapters25; it is considered to play an important role in TIR-TIR interactions21. The DD loop region appears to 
have distinct characteristics only found in IL-1R, TLR5 and MyD88, namely a PI3K motif17. There is some evi-
dence for PI3K activation being important for TLR5 signalling in humans and mice leading to enhanced17,26 or 
inhibited responses27 which may depend on distinct catalytic subunits of PI3K28. Our data provided evidence for 
a significant difference in PIK3 signalling by the bovine and human TLR5s in their cognate cell systems. CXCL8 
production following bTLR5 activation required PI3K but this was not the case for hTLR5 in the HEK cells. 
Signalling differences may stem from variation in adaptor recruitment based on intracellular domains, such as the 
DD loop, of the respective TLRs. Our previous research has shown that there are amino acid differences between 
the TIR domain of bTL5 and hTLR5, including within the DD loop2,7. Our results differ to those of others26 that 
show PI3K is required for down-stream signalling by human TLR5. Ivison et al.17 suggested that the TLR5 DD 
loop contained a predicted PI3K tyrosine phosphorylation site at position 798–801: YQLM thus conforming to 
the PI3K motif YxxM. The authors showed that this tyrosine is phosphorylated following TLR5-flagellin binding, 
and mutation of the tyrosine at position 798 reduced signalling by human TLR5. Nevertheless, they did not show 
that hTLR5 recruits PI3K directly. Furthermore our data shows that while CXCL8 secretion in response to bTLR5 
is PI3K-dependent (and hTLR5 not so), this PI3K motif is not present in bTLR57 and yet it is able to signal. In fact, 
when we mutated the motif to instate the Tyrosine (bTLR5F798Y) this had a clear negative impact on the capacity 
of the bTLR to activate signalling in bovine cells, and a small but significant reduction of CXCL8 production in 
human cells at a lower concentration of flagellin.
However, our results indicate that PI3K activation is a necessary step in signalling from bTLR5-flagellin acti-
vation. It is unlikely that the motif region is phosphorylated by tyrosine kinases which then lead to PI3K recruit-
ment. Instead this motif or local context within the DD loop may be important for effective signalling, potentially 
interacting with the BB loop of TLR5 itself during dimerization as well as the BB loop of MyD88 as indicated 
for other TLRs13,15,21. As suggested by Rhee et al.26, although in the context of hTLR5, TLR5-flagellin activation 
of PI3K is likely to be indirect with PI3K recruited via the adapter molecule MyD88. In fact several other TLR 
molecules are also phosphorylated by tyrosine kinases following ligand binding and some at least may also acti-
vate PI3K indirectly, although many details remain to be elucidated29. PI3K consists of a regulatory and catalytic 
subunit, with a number of different versions of both subunits, including splice variants, the expression of which 
lead to different effects in different cells30. The class IA PIK3R1 gene encodes its regulatory subunit that consists 
of 3 splice variants, of which p85 is generally the most highly expressed. Knock-down of all three splice variants 
in HEK cells had no effect on hTLR5 activation, whereas in EBL siRNA specific for p85 significantly inhibited 
bTLR5 activation. Differences in the involvement of the class I catalytic subunits in TLR5 signalling in humans 
and mice have also been reported28.
The downstream pathways from TLR5/MyD88/PI3K involve TRAF6, NFκB and MAPKs including p38 and 
we found that activation of all three were essential for signalling by both human and bovine TLR5, confirming 
earlier human and mouse studies22,27. However, there were some differences in the way bTLR5 and hTLR5 signal-
ling were affected by the siRNA duplexes and established inhibitors for the NFκB and p38 pathways. Knock down 
of RELA by siRNA inhibited the flagellin response by both hTLR5 and bTLR5. In agreement the NFκB inhibitor 
PDTC inhibited the response by hTLR5. In contrast, a greatly enhanced response was observed for bTLR5. RELA 
is the most common component of the NFκB complex, which can consist of distinct homo or hetero-complexes 
of at least five components. Thus, it is clear that both TLR5 molecules can act through NFκB, but there may be 
species differences in the other NFκB components involved that are differentially influenced by PDTC. The pres-
ence of the p38 inhibitor SB203580 resulted in inhibition of signalling by TLR5 of both species and knock down 
by siRNA for bovine p38 also prevented both molecules from signalling. However, the human p38 siRNA was 
a proprietary siRNA which successfully reduced expression of p38 transcripts, but did not inhibit the CXCL8 
response by hTLR5. As p38 also consists of four distinct isoforms, it is possible that further subtle differences in 
the signalling pathways between humans and cattle TLR5 may be found. Additionally, inhibitors are not always 
completely specific for their main target molecule e.g. SB203580 has been reported to inhibit protein kinas B (or 
Akt)31 and possibly this may account for the lack of effect of the p38 siRNA in the HEK cells.
Our work also clearly challenges the conclusions of Osvaldova et al.9 who had suggested that because bTLR5 
does not have Tyr at position 798, with the equivalent bovine sequence being F-H-L-M, it cannot stimulate a 
down-stream response to flagellin. They reported that exchange of the bovine F-H with a human Y-Q partially 
restored bovine bTLR5 activity in a HEK cell line, though not to the level seen with hTLR5. Our own data indi-
cates that bTLR5 in the presence of flagellin induces a strong downstream response in various cell types includ-
ing HEK cells7 and in fact the bTLR5F798Y variant in the bovine cell was unable to signal effectively. As we 
have shown in this paper, these discrepancies may be because bTLR5 does not interact optimally with human 
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downstream adaptors and/or signalling molecules. The differences may also relate to the enhanced expression of 
bTLR5 in our system where over 90% of the cells were expressing bTLR5 at high levels. It is unclear what effects, 
if any, might be observed in our system if Q799H was also instated in bTLR5.
These studies confirm that we are only beginning to understand the complexity of the regulation underlying 
these critical and overlapping signalling networks. They emphasise that drawing universal conclusions from indi-
vidual species can be over simplistic, and investigations between species in their responses should be considered 
in species relevant cells.
In addition to variation in signalling responses, it is possible that TLR5 has evolved in different host species 
to recognise distinct bacterial flagellins potentially reflecting the relative exposure of that host to that group of 
organisms and their pathogenic potential. Our earlier paper2 had revealed differences in the amino acid sequences 
between the ectodomains of human and bovine TLR5, some of which appear to be under selective evolutionary 
pressure. Since that paper was published only a soluble region of the extracellular domain of the fish species Danio 
rerio TLR5 has been co-crystallised with flagellin ligands, enabling flagellin binding sites to be identified10,32. In 
addition, an electron microscopy study has allowed a model to be built of human TLR5 dimers, with and without 
ligands33. Yoon et al.10 identified an important interaction of LRR9, which forms a flexible loop extending from 
the horseshoe conformation of TLR5, with the D1 domain of flagellin. A conserved residue, R90, in the flagellin 
D1 domain interacts with several amino acids in the LRR9 loop and plays an important role in the activation of 
human TLR511, bovine TLR57 and mouse TLR519. Our previous work demonstrated a non-synonymous poly-
morphism in cattle as well as a ruminant specific site within the LRR9 region of bovine TLR5)2.
Thus, extracellular TLR5 variation may also result in host species-specific responses to distinct flagellins. 
TLR5 is currently only established to recognise the bacterial flagellin monomer as its activating ligand and 
while the two key regions of the flagellin D1 domain known to interact with TLR5 are relatively conserved, 
these regions can still vary substantially between bacterial species. While the Salmonella and Escherichia flagellin 
used in this study have very similar TLR5-interacting D1 sequences, these differ significantly in the Listeria and 
Burkholderia flagellins selected for our analysis. However, several amino acids are conserved between all five 
flagellin sequences. In particular, R90, E114 and Q97 make nearly 20% of the total interactions with the TLR5 
binding sites. These form interactions with mainly conserved TLR5 contacts and may encompass a critical scaf-
folding for effective flagellin-TLR5 binding and signalling. Indeed Ala mutations in R90 or E114 have the greatest 
impact on zebra-fish TLR5 signalling32.
There are a few exceptions: R90 forms an H-bond with the base of the LRR9 cleft which is S267 in zebra-fish 
TLR5 and Ser is present at this site in most other species. However, primates, including humans express Ala at this 
site, and a few other species such as mice express Pro. The latter is sufficient to account for differences in flagellin 
interaction between humans and mice34.
We have also shown that additional positively selected sites in Bos and Ruminantia species exist, some of 
which (G104, S128, Q207 and G239) interact with conserved flagellin sites (Q89, Q97 and A427).
A further three Bos-specific exchanges (F179, K181 and R261) might account for differences between bTLR5 
and hTLR5 in their activation by B. thailandensis and L. ivanovii flagellins, as these three sites interact with dis-
tinct binding amino acids in these flagellins (L. ivanovii: D78, S82, S419, R433; B. thailandensis: S78, T82, N419, 
Q422). Although our data is preliminary, flagellin from B. thailandensis activated hTLR5 to a greater degree than 
L. ivanovii flagellin whereas the reverse was observed for bTLR5. Nonetheless, the flagellins were only compared 
at a single dose and their binding kinetics could provide data that are more conclusive. Further mutagenesis 
experiments are also warranted to test whether these differences in host and flagellin sequences may result from 
different host-pathogen life histories. Burkholderia flagellin has an identical sequence to that expressed by the 
important human pathogen Burkholderia pseudomallei, which can also cause disease in many animals including 
cattle35 whereas L. ivanovii is a ruminant specific pathogen36.
In conclusion we have confirmed that bTLR5 is fully functional, and that both bTLR5 and hTLR5 signal 
more effectively following flagellin interaction when they are expressed in cells containing cognate signalling 
partners. Comparison of the TIR sequences of TLR5 would suggest that the most likely candidate is the initial 
adapter, MyD88, but other signalling partners cannot be ruled out, as we found subtle differences in responses in 
the presence of specific inhibitors and siRNA knock-down of known components of TLR signalling. Sequence 
comparisons of different flagellins which have distinct host outcomes may interact with distinct host TLR5 
binding sites and analysis of these differences has suggested further targets for mutation and confirmation of 
structure-function relationships. Species differences may also impact on the use of flagellin as a vaccine adjuvant. 
Thus delineating species specific activation and signalling is required for the most effective exploitation of this 
activity and to better understand host-bacterium co-evolution in different animal hosts.
Materials and Methods
Flagella expression and purification. E. coli H7 (Ec H7), S. Typhimurium P1 (St P1), Burkholderia 
thailandensis FliC (Bt FliC) and Listeria ivanovii PAM55 FlaA (Li FlaA) flagella were prepared and purified as 
described previously for E. coli7,37. Listeria ivanovii PAM 5536 was cultured overnight in 100 ml brain-heart infu-
sion (BHI, Difco-BD) and then diluted 1:100 into fresh BHI and cultured at 22 °C with shaking [200 rpm] until 
stationary phase. Bacteria were harvested by centrifugation [4,500 rpm, 4 °C, 7 min]. B. thailandensis38 was cul-
tured in LB broth for flagella extraction following the same methodology.
All flagella preparations were stored at −20 °C in PBS. All flagella underwent rigorous lipopolysaccharide (LPS) 
removal as described previously7. In brief this was repeated extraction in 1% Triton × 114, with the final aqueous 
phase for each species’ flagella applied to Pierce® High-Capacity Endotoxin binding resin following the manufactur-
er’s instructions (Thermo Scientific). Endotoxin levels were assessed as described previously7. Before use in experi-
ments all flagella were monomerised by heat treatment7. Flagella were then stored in aliquots at −20 °C.
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Cell lines. In our previous work7, Human Embryonic Kidney (HEK) cells were used, but we observed that 
un-transfected HEK cells did have a low level response to flagellin, potentially because of some endogenous expression 
of human TLR5. In this study we switched to using HEK-293T cells, as in our hands these un-transfected cells showed 
no CXCL8 production in response to flagellin at any concentration (see Fig. 1) in contrast to HEK cells7. Un-transfected 
EBL also did not respond to increasing levels of flagellin, although they did express low levels of CXCL8 (See Fig. 1). 
HEK-293 T (HEK) cells and embryonic bovine lung epithelial cells (EBL) (Leibniz Institute DSMZ-German Collection 
of Microorganisms and Cell Cultures) were cultured at 5% CO2 and 80% humidity in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% (v/v) FBS (Sigma-Aldrich, UK), 1 U of penicillin (Invitrogen Life 
Technologies, BV, Netherlands), 1 µg/mL of streptomycin (Invitrogen) and 2 mM L-glutamine (Invitrogen).
TLR5 clones. The full length of bovine TLR5 was amplified and sub-cloned into the modified ptGFP1 
expression vector as previously described7,12. A similar approach was carried out to amplify hTLR5 (InvivoGen, 
Toulouse, France) using specific primers encoding the full length of the gene alongside restriction enzymes 
sites HindIII and SacII: hTLR5ptGFP-FW:CTGAGCAAGCTTCACCATGGGAGACCACCTGGAC, hTL-
R5ptGFP-RV: CGACATCCGCGGTTAGGAGATGGTTGCTAC.
As previously described, amplified products were transformed into competent XL1-Blue Competent Cells 
(Stratagene, Agilent Technologies Division, USA); plasmid DNA from four independent colonies was purified 
and sent for sequencing to confirm correct sequences. The confirmed hTLR5 plasmid and the modified ptGFP1 
vector were then digested with HindIII and SacII, correct fragments purified, and ligated overnight and trans-
formed into competent JM109 cells (Promega, Madison, USA), with selection on LB agar with kanamycin (50 µg/
ml), followed by culturing overnight in LB medium with kanamycin (50 µg/ml). Plasmid DNA was purified using 
a QIAprep Plasmid DNA Miniprep kit (Qiagen Inc., Netherlands) and concentrations determined by spectropho-
tometry (Nanodrop, Labtech International, UK).
Site-directed TLR5 mutagenesis. The site directed mutation, F798Y in the cytoplasmic domain of TLR5 was gen-
erated using the QuikChange Site-Directed Mutagenesis Kit (Agilent technologies), following the manufacturer’s proto-
cols. The primers used for these reactions were: forward primer 5′-GTCCCTGTCCCAGTACCATCTGATGAGGC-3′ 
and reverse primer 5′-GCCTCATCAGATGGTACTGGGACAGGGAC-3′. Amplified and treated constructs were 
transformed into E. coli XL10-Gold Ultra competent bacteria and plated on E. coli Fast-Media® Blas agar plates 
(InvivGgen) and incubated overnight on 37 °C. Plasmids were extracted, sequenced (DNA Sequencing by GATC 
Biotech, Germany) and analysed using Lazergene software (http://www.dnastar.com). The mutated F798Y bTLR5 was 
then sub-cloned into the modified ptGFP1 vector and F798Y bTLR5 expressing cell lines derived according to the 
method described below.
Transfection of cell lines with TLR5 clones. For transfection, EBL and HEK-293T cells were incubated 
in supplemented DMEM as described above. Cells were passaged 48 h prior to transfection by electroporation 
with 2 μg of bTLR5-ptGFP1, hTLR5-ptGFP1 construct or empty ptGFP1 vector (control) in a Nucleofector™ 2d 
Device (Lonza Group Ltd., US) as detailed previously7. After 24 h, all media were replaced with fresh media sup-
plemented with 500 μg/ml of neomycin (G418, Sigma Aldrich). This was replenished every day to remove dead 
cells, and the concentration of neomycin reduced to 250 μg/ml, one week following transfection.
Once around 25–50% of the cells were GFP positive, they were cell sorted using a FACSAria™ III which gener-
ated cultures of >90% GFP+ cells after one or more rounds of sorting, except for the F798Y mutant in EBL which 
persistently through several rounds of sorting contained a small proportion of GFP- cells (Supplementary Fig. S1). 
Once the desired enrichment was achieved each cell line was frozen in aliquots. RT-PCR was used to confirm 
the expression of the constructs in the transfected EBL and HEK-293T cell line, including empty vector control 
lines. The primers used for identification of bovine TLR5 and endogenous control bovine GAPDH (bGAPDH) in 
the bTLR5-ptGFP1 and F798Y-bTLR5-ptGFP1 cell lines are detailed elsewhere7. The forward primer for hTLR5 
matched sequence in the 3′ end of human TLR5 (hTLR5-FW: AGAAAACCGCATTGCCAATATC) whilst the 
reverse primer (ptGFP1-hTLR5-RV: CTGATTATGATCTAGAGCCGCGGTTAGGAGA) was designed to span 
both hTLR5 and ptGFP1. The reactions (25 μl) were an initial denaturation of 2 min at 95 °C, followed by 35 cycles 
of 95 °C for 30 s, 60 °C for 30 s and 72 °C for 45 s. All PCR products were visualised on a 1% agarose gel containing 
SYBR® Safe DNA Gel Stain (Life Technologies, BV, Netherlands). Each construct was present in both EBL and 
HEK cell lines (Supplementary Figs S7 and S8).
CXCL8 ELISA. The read-out for TLR5 activity in all experiments was CXCL8 secretion into cell line culture 
supernatants. Cell lines were prepared at 5 × 105 cell per ml and 180 μl/well was added to each well in a 96-well 
plate, with the addition of 20 μl/well flagellin at final concentrations as required (see results). Following overnight 
incubation, cell culture supernatants were harvested for assays. Human CXCL8 protein levels were measured by 
ELISA using the BD OptEIA human IL-8 ELISA set (BD Biosciences) following the manufacturer’s instructions. 
Bovine CXCL8 protein release was measured by ELISA as described previously7. All ELISAs were carried out 
using Nunc-Immuno Maxisorp 96 well plates, with all samples and standards in triplicate. The plates were read 
using a Synergy HT plate reader (BioTek).
Inhibitors of innate signalling pathways. Cell lines were prepared at 5 × 105 cell per ml and the follow-
ing inhibitors were added: PI3K inhibitor LY294002 (50 μM), (Calbiochem, San Diego, CA, USA), p38α and p38β 
inhibitor, SB203580 (5 μM) (InvivoGen) and NFκB inhibitor, PDTC (100 μM) (AbMole BioScience Inc., Brussels, 
Belgium), with DMSO as a vehicle control. The cells were vortexed and 180 μl/well of the cells were added to 96 
well plates. The cells were incubated for an hour before adding H7 flagellin at a final concentration of 25ng/ml. 
The cell lines were then incubated overnight, and supernatants were collected for CXCL8 ELISA analysis. Each 
experiment was carried out in triplicate and repeated three times.
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siRNA knock-down. Previously designed and validated siRNA for human p38, RELA, TRAF6 and PIK3R1 
were obtained from Sigma-Aldrich (Supplementary Table S2). Three siRNA duplexes for the bovine homologue 
of each gene were designed by Sigma-Aldrich and assessed for their ability to knock-down target gene mRNA 
levels. One siRNA for each gene, which gave optimal knock-down with minimum off-target effects, was chosen 
for the analysis (Supplementary Table S3), except for PIK3R1. In addition, the AllStars negative control siRNA 
(Qiagen), which does not share homology with any known mammalian gene, was used as a non-target siRNA 
control (NTC).
For the siRNA experiments HEK-hTLR5 and EBL-bTLR5 cell cultures were prepared at 2 × 105 and 1 × 105 
cells per ml respectively and 1 ml/well was added to each well of a 12 well plate. After 24 hr HEK-hTLR5 cells 
were transfected with siRNA following the manufacturer’s protocol at predetermined optimal conditions, initially 
generating a mix of 5 μl Lipofectamine RNAiMAX and 5 μl 20 μM siRNA in 200 μl Opti-MEM I reduced serum 
medium (Invitrogen). After 20 min incubation at room temperature the siRNA/Lipofectamine RNAiMAX mix 
was added to the cells in 1 ml medium, giving a final concentration of 83.3 nM siRNA. EBL-bTLR5 cells were 
transfected in a similar manner, using 4 μl Lipofectamine RNAiMAX and 4 μl 20 μM siRNA in 200 μl Opti-MEM 
I reduced serum medium (Invitrogen), giving a final concentration of 66.7 nM siRNA. Additional controls 
included in each experiment were cells treated with Lipofectamine RNAiMAX only (transfection control, TC) 
and untreated cells (negative control, NC). After 24 hr the cells were stimulated with 100 ng/ml E. coli H7 flagel-
lin. Cells were harvested at 4 hr post stimulation for RNA extraction and supernatants were collected 24 hr post 
stimulation for CXCL8 ELISA analysis. Each experiment was carried out in triplicate and repeated three times.
Reverse transcription: quantitative PCR (RT-qPCR) analysis of target gene knock-down. Total 
RNA was extracted from all HEK-hTLR5 and EBL-bTLR5 samples using the ReliaPrep RNA extraction kit 
(Promega), including a DNase digestion step, according to the manufacturer’s instructions. First strand cDNA 
was reverse transcribed from 0.5 μg total RNA using an oligo(dT) primer and GoScript reverse transcriptase 
(Promega) according to the manufacturer’s protocols. The resulting cDNA was diluted 1:20 for RT-qPCR anal-
ysis. Pre-designed oligonucleotides for human p38, RELA, TRAF6 and CHAMP1 were used in the analysis 
(Sigma-Aldrich) (Supplementary Table S3). Oligonucleotides for human PIK3R1 and bovine target genes were 
designed using Primer339 and Netprimer (Biosoft International) software (Supplementary Table S3). The mRNA 
level of each transcript was quantified by qPCR as described previously7. CHAMP1 was found to be a suitable ref-
erence gene, with stable expression across HEK and EBL samples (data not shown), and was used to standardize 
the results for the genes of interest. All siRNAs led to specific knock-down of mRNA, with no off-target effects 
except for PI3KR#b1 (results not shown) which was excluded in the final analysis (Supplementary Fig. S9 and 
see Results section). The average level of knock-down of the four target genes in HEK-hTLR5 cells ranged from 
58.3% for PIK3R1 to 69.5% for RELA (Supplementary Fig. S9(a)). A higher level of knock-down was achieved 
in EBL-bTLR5 cells. The average level of knock-down ranged from 79.2% for p38 to 89.1% for PIK3R1 with 
PIK3R1#b3 siRNA (Supplementary Fig. S9(b)).
Sequence alignment and comparative analysis of TLR5 and flagellin domains. Nucleotide 
sequences encoding TLR5 were obtained from GenBank and Ensembl and the horse TLR5 sequence was kindly 
provided by Dr James MacLeod, University of Kentucky, USA (Supplementary Table S1). Translated protein 
sequences were aligned using Clustal Omega40 and visualised using Jalview41. Domains and putative functional 
sites were mapped according to2 and10 for TLR5 and by analogy with other TIR domain proteins13,14. The fol-
lowing flagellin sequences were obtained from Uniprot, their Nt and Ct D1 domains aligned and amino acids 
involved in TLR5 binding mapped according to published data10,11: B. thailandensis FliC (WP_009906598.1), E. 
coli 0157 H7 (Q7AD06), L. ivanovii (strain ATCC BAA-678 / PAM 55) FlaA, (G2ZCV3), S. Typhimurium str. FliC 
(P06179) and S. Dublin FliC (Q06971).
Statistical analysis. All experiments were conducted on three separate occasions using separate aliquots of 
cell lines and flagella, and with triplicate technical replicates. All statistical analyses were carried out using Minitab 
version 17. All the data were log transformed before statistical analysis which accounted for both the within and 
between experiment variance. The effects of siRNA and inhibitors were analysed using an ANOVA model fitting 
experiment as random effects and treatment (siRNA or inhibitor) as fixed effects. Subsequent Tukey’s tests were 
used to identify significant differences between treatments.
Data Availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files) and TLR5 sequences used in the alignments were obtained from Genbank 
and/or Uniprot (See Supplementary Table S1).
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